Company news
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Resignation of vice chairman and executive director
May 6, 2021
Shenzhen Hepalink Pharmaceutical Group: Voluntary announcement"heptris" obtains approval from brazilian health regulatory agency
April 21, 2021
(1) Resignation of non-executive director (2) proposed appointment of executive director
April 20, 2021
Shenzhen Hepalink Pharmaceutical Group: Voluntary announcement - "inhixa" obtains approval from north macedonia
April 13, 2021
Voluntary announcement settlement of the disposal of shares of kymab
April 9, 2021
Shenzhen Hepalink Pharmaceutical Group: "Enoxaparin sodium injection" obtains approval from FDA
September 21, 2020
Change of joint company secretary and authorized representative and waiver from strict compliance with rules 3.28 and 8.17 of the listing rules
September 18, 2020
Change of principal place of business in hong kong
September 11, 2020
Shenzhen Hepalink Pharmaceutical Group: Hepalink Announces 2020 Interim Results
August 30, 2020
Shenzhen Hepalink Pharmaceutical Group: Hepalink Announces Exciting Regulatory Developments
June 28, 2020
Shenzhen Hepalink Pharmaceutical Group: Hepalink Announces the Appointment of Healthcare Senior Executive Mr. Frank Sun as Executive Director and Vice Chairman of the Board
March 5, 2020